Previous 10 | Next 10 |
Repro Med Systems ( OTCQX:REPR ): Q1 GAAP EPS of $0.00 misses by $0.01 . More news on: Repro Med Systems, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Record Quarterly Net Sales of $5.0 Million, Up 23% From Prior Year Conference Call Scheduled for May 1 at 9:00 am ET Q1 2019 Overview Net sales rose 23.3% from prior year to $5.0 million - a quarterly record Gross margin of 61.3% HIgh-Flo Super26™ Subcut...
Kathy S. Frommer Elected to the Board of Directors Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) (“RMS Medical”) today announced that shareholders voted in favor of all items of business put forth at the company’s Annual Meeting of Shareholders ...
Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) (“RMS Medical”) today announced that Arthur J. Radin, a valued and trusted member of the company’s Board of Directors, died unexpectedly on April 24, 2019 at his home in New York. “Arthur was a l...
Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced that it will release its financial results for the first quarter ended March 31, 2019, after the close of the financial markets on Tuesday, April 30, 2019. Management will host a conference call on Wednesday, Ma...
Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) (RMS Medical) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) for its HIgh-Flo Super26™ Subcutaneous Needle Sets (“Super 26 Needl...
CHESTER, NY / ACCESSWIRE / March 15, 2019 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced that Dan Goldberger, Executive Chairman, will be presenting at the 29th Annual Oppenheimer Healthcare Conference in New York, NY on Tuesday, March 19th. Slides from man...
CHESTER, NY / ACCESSWIRE / February 21, 2019 / Repro Med Systems, Inc. dba RMS Medical Products (RMS Medical) (OTCQX: REPR) today announced that Brian Schiller, PhD, has been hired as the Vice President of Medical Affairs. ''Dr. Schiller is a proven leader within the pharmaceutical medical ...
Repro Med Systems ( OTCQX:REPR ): FY net income of $0.9M. Revenue of $17.4M (+13.0% Y/Y) Press Release More news on: Repro Med Systems, Inc., Earnings news and commentary, Healthcare stocks news, ,
Reported record 2018 revenue of $17.4 million, up 12.4% compared to 2017 Improved 2018 Profitability; improved Gross Margin, record Net Income and Adjusted EBITDA Significant progress made in strengthening management team and Board in 2018 Strategic Plan adopted with goal...
News, Short Squeeze, Breakout and More Instantly...
Repro Med Systems Inc Company Name:
REPR Stock Symbol:
OTCMKTS Market:
Repro Med Systems Inc Website:
New Ticker Symbol “KRMD” Repro Med Systems, Inc. (NASDAQ: REPR) (“the Company”) today announced a new dba name, KORU Medical Systems, which the Company will begin using in place of RMS Medical Products on October 24, 2019. Reflecting this change, the Com...
Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) (“RMS Medical” or “the Company”) today announced that its common stock has been approved for listing and is expected to begin trading on the NASDAQ Capital Market on October 17, 2019 under the current...
Repro Med Systems, Inc. dba RMS Medical Products (“RMS Medical”) (OTCQX: REPR) today announced that R. John Fletcher has been appointed Chairman of the Board. Mr. Fletcher succeeds Daniel S. Goldberger who has resigned as Executive Chairman of RMS Medical in connection with hi...